HDR brachytherapy as a single-day monotherapy: Survival results of a phase II randomized trial

被引:0
|
作者
Jolicoeur, M. [1 ]
Derashodian, T. [1 ]
Nguyen-Huynh, T.
Hillmann, E. [1 ]
Denis, T. [1 ]
Heliou, R. [1 ]
机构
[1] Hop Charles LeMoyne, Radiat Oncol, Greenfield Pk, PQ, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OC-0102
引用
收藏
页码:S70 / S70
页数:1
相关论文
共 50 条
  • [21] Clinical outcomes of HDR-prostate brachytherapy 19Gy single fraction: prospective phase II trial
    Gomez-Iturriaga, A.
    Casquero, F.
    Buchser, D.
    Minguez, P.
    Espinosa, J.
    Perez, F.
    Cacicedo, J.
    San Miguel, I.
    Suarez, F.
    Pijoan, J.
    Bilbao, P.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S147 - S147
  • [22] What is the proper dose in single fraction HDR brachytherapy as monotherapy for prostate cancer?
    Ruiz Arrebola, S.
    Tornero-Lopez, A. M.
    De la Vega, J. M.
    Prada, P. J.
    Guirado, D.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S972 - S973
  • [23] A Planning Study: Escalating the Single Fraction Monotherapy Dose for HDR Prostate Brachytherapy
    Sabondjian, Eric
    Sankreacha, Raxa
    Yuen, Jasper
    Rauth, Sarah
    MEDICAL PHYSICS, 2019, 46 (11) : 5378 - 5378
  • [24] Toxicity and Quality of Life Outcomes from a Randomized Phase II Trial of HDR Monotherapy for Low and Intermediate-Risk Prostate Cancer
    Hasan, Y.
    Loblaw, D. A.
    Chung, H. R.
    McGuffin, M.
    Tseng, C. L.
    Mendez, L. C.
    Ravi, A.
    Zhang, L.
    Mamedov, A.
    Morton, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S133 - S133
  • [25] A Single-Day Training for Managers Reduces Cognitive Stigma Regarding Mental Health Problems: A Randomized Trial
    Gast, Michael
    Lehmann, Janina
    Schwarz, Elena
    Hirning, Christian
    Hoelzer, Michael
    Guendel, Harald
    Balint, Elisabeth Maria
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (07)
  • [26] Oral Sulfate Solution versus Polyethylene Glycol as a Single-Day Preparation for Colonoscopy: A Randomized Control Trial
    Shah, Bhavik Bharat
    Patel, Bubun
    Goenka, Mahesh Kumar
    JOURNAL OF DIGESTIVE ENDOSCOPY, 2019, 10 (03) : 174 - 177
  • [27] HDR brachytherapy combined to EBRT for prostate cancer: analysis of toxicities and PSA bounce of a phase II trial
    Tetreault-Laflamme, A.
    Nguyen, T. V.
    Vincent, F.
    Saad, F.
    Benoit, N.
    Fortin, B.
    Lambert, C.
    Jolicoeur, M.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S566 - S566
  • [28] First report of an institutional phase I-II trial of perioperative fractionated HDR brachytherapy (PHDRB)
    Martínez-Monge, R
    Cambeiro, M
    Garrán, C
    Jurado, M
    Alcaide, J
    San Julián, M
    Amillo, S
    Concejo, C
    Hernández-Lizoain, J
    Pardo, F
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S60 - S61
  • [29] High-Dose-RATE Brachytherapy As Monotherapy for Low and Intermediate Risk Prostate Cancer: ACUTE Toxicity of a Randomized Phase II Trial
    Jolicoeur, M.
    Derashodian, T.
    Nguyen-Huynh, T. V.
    Hellmann, E. de Castro
    Mondat, M.
    Nachabe, M.
    Antebi, E.
    Wakil, G.
    Heliou, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E284 - E284
  • [30] Phase II Trial of image-based HDR interstitial brachytherapy for previously irradiated gynecological cancer
    Olarte, A.
    Valtuena, G.
    Cambeiro, M.
    Moreno, M.
    Aristu, J. J.
    Arbea, L.
    Ramos, L.
    Barbes, B.
    Azcona, D.
    Martinez-Monge, R.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S149 - S149